Effects of COVID-19 on the Federal Research and Development Enterprise by the Congressional Research Service, Daniel Morgan, and John F. Sargent Jr. April 10, 2020. COVID-19 Professional Reading
Written while still in the early phases of the uneven and partial COVID-19 shutdown across the United State, this report outlines many of impacts of the pandemic on Federal research. The report provides a good overview of the likely areas of impact. As the report notes:
As the scientific, government, and public understanding of COVID-19 has grown, the national response has evolved, and it is likely to continue to evolve. The scope, scale, and dynamism of responses by the federal government, state and local governments, and the private sector are too great to catalog fully in this report. Rather, the report highlights key effects and issues of concern and provides examples of agency actions (p. 1).
Also, it was clear from the outset that many Federally funded research efforts would pivot to COVID-19 research:
Even for continuing R&D projects, there may be efficiency and quality impacts, additional costs, and challenges such as the closure of suppliers and service providers. Some resources dedicated to ongoing R&D are also being redirected toward work focused on COVID-19 (unpaged).
Since many Federally funded research efforts take place with partners in academia, the impact of COVID-19 would be mitigated (or exacerbated) by the uneven response of many academic institutions:
University decisions about essential research functions may be informed by local conditions, federal funding agency directives, ethical considerations about the well-being of human subjects and animals in discontinued or scaled-back research, and each university’s own risk management decision making (p. 3).
Likewise, differences in disciplines are important differentiators of impact:
These factors may affect different disciplines differently; for example, research in mathematics, computer science, and theoretical physics may be more amenable to remote working than research in agricultural science, geology, or microbiology (p. 4).
The report also outlines some of the measures and actions that the Coronavirus Preparedness and Response Supplemental Appropriations (CARES) Act identifies for Federally supported research activities, such as providing no-cost extensions to Federal grants. A specific action that Congress may consider is:
establishing a post-pandemic task force on the federal R&D enterprise to
examine lessons learned from the COVID-19 pandemic and recommend policy
changes to improve the national response of the R&D community in the event of
future pandemics (p. 14).
One can wish …
Recommended reading in conjunction with What Happens to the Continuity and Future of the Research Enterprise?: Report of a CNI Executive Roundtable Series Held April 2020. See review here.
Read: July 5, 2020 | Find Online
See my complete 2020 Reading list on Goodreads.